2′-Fucosyllactose impacts the expression of mucus-related genes in goblet cells and maintains barrier function of gut epithelial cells
Scope: Cost-effective microbial biosynthesis of 2′-fucosyllactose (2′-FL) allows its application in infant formula. The specific effects of 2′-FL on the gastrointestinal immune barrier are still largely unknown. Methods/results: Here, we quantified and compared the effects of HMOs isolated from huma...
Main Authors: | Susana Figueroa-Lozano, Renate Akkerman, Martin Beukema, Sander S. van Leeuwen, Lubbert Dijkhuizen, Paul de Vos |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-10-01
|
Series: | Journal of Functional Foods |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1756464621002796 |
Similar Items
-
Evidence of Human Milk Oligosaccharides in Cord Blood and Maternal-to-Fetal Transport across the Placenta
by: Birgit Hirschmugl, et al.
Published: (2019-11-01) -
Safety of 2’‐fucosyllactose/difucosyllactose mixture as a novel food pursuant to Regulation (EU) 2015/2283
by: EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), et al.
Published: (2019-06-01) -
Bifidobacterium infantis Metabolizes 2′Fucosyllactose-Derived and Free Fucose Through a Common Catabolic Pathway Resulting in 1,2-Propanediol Secretion
by: Liv R. Dedon, et al.
Published: (2020-11-01) -
HMOs modulate immunoregulation and gut microbiota in a β-lactoglobulin-induced allergic mice model
by: Tingting Liu, et al.
Published: (2020-07-01) -
Safety of 2′‐O‐fucosyllactose as a novel food ingredient pursuant to Regulation (EC) No 258/97
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
Published: (2015-07-01)